Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $7.2400 (-0.07%) ($7.2400 - $7.2400) on Fri. Aug. 4, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.26% (three month average) | RSI | 23 | Latest Price | $7.2400(-0.07%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | IOVA declines -4% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) GLD(55%) EDOC(25%) SLV(24%) IGOV(23%) XBI(21%) | Factors Impacting IOVA price | IOVA will decline at least -2.63% in a week (0% probabilities). UUP(-29%) XLU(-24%) TBT(-22%) XME(-21%) VYM(-20%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.63% (StdDev 5.26%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.53 | 5 Day Moving Average | $7.21(0.42%) | 10 Day Moving Average | $7.18(0.84%) | 20 Day Moving Average | $7.53(-3.85%) | To recent high | -20.5% | To recent low | 6.3% | Market Cap | $1.06b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |